Oakmont Advisory Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$352K Buy
3,844
+342
+10% +$29.9K 0.3% 93
2026
Q1
$299K Sell
3,502
-642
-15% -$57.2K 0.3% 103
2025
Q4
$327K Buy
+4,144
New +$325K 0.35% 88

Other funds holding CL

Oakmont Advisory Group's CL Position: Q2 2026 in Review

Oakmont Advisory Group increased its Colgate-Palmolive (CL) stake by 9.8% in Q2 2026, buying an estimated $29.9K and bringing the position to 3,844 shares worth $352K. The position accounts for 0.3% of the portfolio, ranked #93.

Oakmont Advisory Group first reported a position in CL in Q4 2025 and has held it in 3 quarters since. 2,003 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Oakmont Advisory Group held 3,844 shares of Colgate-Palmolive worth $352K as of Q2 2026.
  • Oakmont Advisory Group bought 342 Colgate-Palmolive shares in Q2 2026, an estimated $29.9K.
  • Colgate-Palmolive made up 0.3% of Oakmont Advisory Group's portfolio in Q2 2026, its #93 holding.
  • Oakmont Advisory Group first reported a position in Colgate-Palmolive in Q4 2025 and has held it in 3 quarters since.
  • 2,003 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Oakmont Advisory Group's 13F filing for Q2 2026, filed 3 Aug 2026.